Clinical Trial

DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC)

Study acronym: DMEC
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated December 1, 2022 (before its estimated June 2024 completion). Its status may not reflect the trial's current state.
Summary
The DMEC trial is a randomized clinical two-arm trial comparing inflammation and cystoid macular edema for the medication regimens postoperative topical NSAIDs and steroids to only postoperative topical steroids in patients undergoing corneal endothelial transplantations (DSAEK or DMEK).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-10-05; most recent amendment 2022-11-26.
Status change: Not Yet Recruiting → Recruiting 2022-11-26
Trial Details
NCT Number NCT05072262
Lead Sponsor Oslo University Hospital
Conditions Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Descemet Membrane Endothelial Keratoplasty (DMEK)
Enrollment 300 participants
Start Date 2022-11-25
Primary Completion 2024-06 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2022-12-01